New Rochelle, NY, United States of America

Richard M LoPachin

USPTO Granted Patents = 3 

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2014-2022

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Richard M. LoPachin

Introduction

Richard M. LoPachin is a notable inventor based in New Rochelle, NY. He has made significant contributions to the field of cytoprotection and toxicology, holding a total of three patents. His work focuses on developing methods and compositions to combat oxidative stress and toxic electrophiles.

Latest Patents

Among his latest patents is a multifunctional cytoprotectant designed for the treatment of pathogenic processes mediated by oxidative stress and toxic electrophiles. This patent discloses various methods, filters, and compositions aimed at treating toxicity resulting from oxidative stress. Another significant patent involves methods and compositions for preventing and treating electrophile-mediated toxicities. This patent highlights the use of 1,3-dicarbonyl compounds to address toxicity caused by therapeutic agents and oxidative cellular damage, as well as to treat liver ischemia-reperfusion injury.

Career Highlights

Richard M. LoPachin is affiliated with Montefiore Medical Center, where he applies his expertise in toxicology and cytoprotection. His innovative approaches have the potential to improve treatment outcomes for various diseases and disorders.

Collaborations

He has collaborated with notable colleagues, including Terrence Gavin and Brian Geohagen, to advance research in his field.

Conclusion

Richard M. LoPachin's contributions to the field of cytoprotection and toxicology through his patents reflect his commitment to addressing critical health challenges. His work continues to pave the way for innovative treatments that can significantly impact patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…